Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Genotype 4 Infection”

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT01467492
What this trial is testing

Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 121
Not applicableStudy completedNCT02581163
What this trial is testing

Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

Who this might be right for
Chronic Hepatitis C, Genotype 1 or 4
AbbVie 314
Testing effectiveness (Phase 2)Study completedNCT01030432
What this trial is testing

Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 285
Not applicableStudy completedNCT02725866
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 216
Large-scale testing (Phase 3)Study completedNCT02265237
What this trial is testing

A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)

Who this might be right for
Hepatitis C Virus
AbbVie 184
Large-scale testing (Phase 3)Ended earlyNCT00423800
What this trial is testing

Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 56
Large-scale testing (Phase 3)Study completedNCT02636595
What this trial is testing

The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)

Who this might be right for
Hepatitis C Virus
AbbVie 121
Testing effectiveness (Phase 2)WithdrawnNCT02556086
What this trial is testing

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Post-approval studies (Phase 4)UnknownNCT03359746
What this trial is testing

Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant

Who this might be right for
Hepatitis C
King Faisal Specialist Hospital & Research Center 40
Testing effectiveness (Phase 2)Study completedNCT04378608
What this trial is testing

Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4

Who this might be right for
Hepatitis C Virus Infection
Beni-Suef University 100
Post-approval studies (Phase 4)Study completedNCT00612755
What this trial is testing

Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4

Who this might be right for
HIV InfectionsHepatitis C
Hospital Clinico Universitario San Cecilio 43
Large-scale testing (Phase 3)Study completedNCT02486406
What this trial is testing

Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 64
Testing effectiveness (Phase 2)UnknownNCT01025297
What this trial is testing

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone

Who this might be right for
Hepatitis C
Cytheris SA 18
Not applicableStudy completedNCT02798315
What this trial is testing

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study

Who this might be right for
Chronic Hepatitis C
AbbVie 40
Not applicableStudy completedNCT00700401
What this trial is testing

POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 262
Large-scale testing (Phase 3)Study completedNCT01641640
What this trial is testing

Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 328
Post-approval studies (Phase 4)Study completedNCT01686789
What this trial is testing

Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4

Who this might be right for
Chronic Hepatitis C Virus
King Abdulaziz Medical City 181
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Large-scale testing (Phase 3)Study completedNCT02651194
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
AbbVie 104
Testing effectiveness (Phase 2)Study completedNCT02262728
What this trial is testing

An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation